Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-22-018101
Filing Date
2022-05-06
Accepted
2022-05-06 16:05:47
Documents
66
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10037286_10q.htm   iXBRL 10-Q 1143714
2 EXHIBIT 31.1 brhc10037286_ex31-1.htm EX-31.1 11467
3 EXHIBIT 31.2 brhc10037286_ex31-2.htm EX-31.2 11400
4 EXHIBIT 32.1 brhc10037286_ex32-1.htm EX-32.1 6021
10 image0.jpg GRAPHIC 63238
  Complete submission text file 0001140361-22-018101.txt   6545346

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rckt-20220331.xsd EX-101.SCH 47918
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rckt-20220331_cal.xml EX-101.CAL 61592
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rckt-20220331_def.xml EX-101.DEF 252438
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20220331_lab.xml EX-101.LAB 705139
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20220331_pre.xml EX-101.PRE 397859
60 EXTRACTED XBRL INSTANCE DOCUMENT brhc10037286_10q_htm.xml XML 1012842
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36829 | Film No.: 22901026
SIC: 2834 Pharmaceutical Preparations